Cite
MLA Citation
C. Rodriguez et al.. “P934: DARATUMUMAB + LENALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: A POST HOC ANALYSIS OF SUSTAINED MINIMAL RESIDUAL DISEASE NEGATIVITY FROM GRIFFIN.” HemaSphere, vol. 6, n.d., pp. 824–825. http://access.bl.uk/ark:/81055/vdc_100159756831.0x00000d